At present, India requires better and affordable health care products for aggressive diseases like cancer. Currently, millions of Indian patients do not have access to right health care products, as they are not available in India. Majority of the hospitals in India still depend on the Western technologies that are not accessible.
With the new Make-in-India initiative introduced by our current Prime Minister, Diagnostring Laboratories believed to be a first Indian company to innovate and develop cancer and genomics based health care and diagnostic products.

DF Automation & Robotics Sdn Bhd is one of the leading robotic company in South East Asia. DF designs and manufactures Automated Guided Vehicle (AGV). AGV is an industrial mobile robot that can move autonomously from one point to another and very useful to carry heavy loads. This is very useful for manufacturing industries as they can reduce labor reliance and increase efficiency. The mobile robotics market worldwide is USD$8.58bn in 2016 and expect to grow to US$30bn by 2025. DF envisions to be one of the leading player in industry mobile robot. DF has developed many patent pending products including Zalpha AGV, Titan AGV, Suki AGV as well as our in-house developed software, NavWiz. NavWiz is an easy to use software to program the AGVs and with IoT enabled feature. DF has sold to many MNC companies includes Sony, Toto, Yamaha, Produa, Jabil, Sanmina, Flex, among others and has exported to Singapore, Thailand, India, Indonesia, Vietnam, Philipines, Mexico, US and UK.

DynaOptics’ technology allows an optical zoom camera module to fit inside the footprint of today’s mobile phone – without the bulky protrusion. Not only will consumers love it as it enables better photos and videos in a slim form-factor, phone OEMs will love it as it employs established high-volume manufacturing techniques and off-the-shelf materials. The smart phone camera lens module market alone, is about $10bn in 2015. Other potential markets include consumer electronic devices (wearables, tablets, laptops), surveillance cameras, medical devices, robotics and defense.

Large farms are very complex to manage especially from the ground view. The thousands of hectares of farmland make it very challenging to monitor effectively. Inefficiency in operations (irrigation, fertilizer and pesticide targeting, etc.) are hard to address without seeing the big picture. And the big picture may only be seen from a thousand feet above! What they need are insights from a higher perspective! Davao UAS Air Map 3D is just that!

Davao UAS is a company that specializes in the technology of unmanned aerial systems (UAS). With over 12 years of Benedick Java’s RC Airplane building experience, combined with Tjader Regis’ 3 years of UAS design and mission solutions, Davao UAS was commercially formed in 2015 to focus this innovative technology into affordable, practical, real-world applications such as aerial photography & videography, live surveillance, digital 3D topographic mapping, and more.

In the last 2 years, the team behind Davao UAS have provided services to the International Rice Research Institute (IRRI), GMA TV, Unifrutti, and various security services. We are also a recognized volunteer of Davao City’s 911 Emergency Response for rapid assessment.

DRD Biotech, R&D company based in Russia, Ulan-Ude city (Buryatia republic).

DRD develop and implements a point-of-care rapid test kits to accelerate and improve the early detection of brain damage. We have a mission to create a simple and affordable solution, requires no technical equipment to accelerate decision support in acute situations such as Stroke management and TBI.

There are two main directions in our pipeline:

• ・Diagnostic assay for assessment of Ischemic Stroke/TIA
• ・Diagnostic assay for assessment the severity of concussion.

The key element of our lateral flow immunoassays are brain biomarkers of brain damage peptides and antibodies of NMDA and AMPA glutamate receptors.

There are several areas of implementation for brain damage immunoassays:

• ・Ambulance and Emergency department (Acute Ischemic Stroke, Strove vs. no Stroke, mTBI)
• ・Rehabilitation and treatment monitoring (to monitoring efficiency of treatment of chronical ischemic events)
• ・Neurosurgery and cardiac surgeries (to avoid risk of ischemic events during and after surgical operations)
• ・Maternity and childbirth (children risk assessment of near-term ischemic events during and after childbirth especially after complicated childbirth)
• ・Screening people with pre-existing conditions such as hypertension, diabetes, artherosclerosis, smoking, alcohol intake, etc. (To accurately risk assessment and monitoring of preventive therapy)
• http://www.drdbiotech.ru/#!home/c1anm

DRD Biotech（DRDバイオテック）はロシアのウランウデ市（ブリヤート共和国）を拠点とする研究開発企業です。

DRDは臨床現場即時検査キットの開発と導入を行っており、脳損傷の診断改善と早期発見に貢献しています。当社は技術的装置を必要としない、脳卒中やTBI（外傷性脳損傷）などの緊急時の診断支援を促進できるような簡素で手頃な価格のソリューションを生み出すことを使命としています。

当社のパイプラインには主に二つの柱があります。

• ・虚血性脳卒中／TIA（一過性虚血発作）を調べるための診断分析
• ・脳震盪の重篤度を調べるための診断薬（装置）

当社の側方流動式免疫検査法の主な要素は、NMDAおよびAMPAグルタミン酸受容体の脳損傷ペプチドおよび抗体の脳バイオマーカーとなっています。

脳損傷免疫検査法が導入される分野はいくつかあります。

• ・救急および緊急診療科（急性虚血性脳卒中、脳卒中の有無や軽度外傷性脳損傷の判定）
• ・リハビリおよび治療のモニタリング（慢性虚血性イベント治療の効率性をモニタリング）
• ・神経外科および心臓外科（外科手術の術中および術後の虚血性イベント発生リスクの回避）
• ・妊娠および出産（出産、特に合併症のある出産の最中および出産後の短時間の虚血性イベントでの小児リスクを査定）
• ・高血圧、糖尿病、関節硬化症、喫煙、アルコール摂取などの既往歴のある患者のスクリーニング（予防的治療のリスク評価およびモニタリングの精緻化）
• http://www.drdbiotech.ru/#!home/c1anm